What is it about?
A robust LC-MS/MS method to quantify tenofovir, emtricitabine, rilpivirine, elvitegravir, and dolutegravir in mouse biological specimens.
Featured Image
Why is it important?
Many patients receive multiple drugs for HIV treatment. An analytical method to quantify several drug compounds is advantageous.
Read the Original
This page is a summary of: Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC–MS/MS and its application to a pharmacokinetic study, Journal of Pharmaceutical and Biomedical Analysis, September 2016, Elsevier,
DOI: 10.1016/j.jpba.2016.07.040.
You can read the full text:
Contributors
The following have contributed to this page
